Lyfebulb
Entity
Description
  • Value proposition

    Connect People. Inspire Change. Impact Lives.

    Lyfebulb is a chronic disease focused, patient empowerment platform that connects patients, industry and investors to support user-driven innovation.

    Health, Diabetes, Chronic Disease, Wellness, Investing, Finance, Cancer, Inflammatory Bowel Disease, Entrepreneurship, and Chronic Illness

  • Lyfebulb

    Our mission at Lyfebulb is to reduce the burden of living with chronic disease through the power of the patient. Learn more here.

    • https://lyfebulb.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Blue Horizon
Blue Horizon
Venture Capital and Private Equity Principals
Blue Horizon
Venture Capital and Private Equity Principals 		Other

30 Apr 2024


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing 		Not capitalistic
Partnership
Event

14 Nov 2017

16 Nov 2022



Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services 		Not capitalistic
Not partnership
Event

8 Nov 2017


IBM
IBM
IT services, IT Services and IT Consulting
IBM
IT services, IT Services and IT Consulting 		Other

4 Aug 2018


McKinsey & Company
McKinsey & Company
Consulting, Business Consulting and Services
McKinsey & Company
Consulting, Business Consulting and Services 		Not capitalistic
Not partnership
Event

28 Oct 2019


Google
Google
IT services, Software Development
Google
IT services, Software Development 		Not capitalistic
Partnership
Not event

27 Apr 2020


Amazon
Amazon
IT services, Consumer Electronics, Software Development
Amazon
IT services, Consumer Electronics, Software Development 		Other

8 Jun 2020


Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing 		Other

26 Jan 2023


Similar entities
Last news
Show all articles
Social network dynamics